Updated recommendations to minimise the risk of the rare brain infection PML with Tecfidera

View source ↗

Summary

EU EMA updates recommendations to reduce risk of progressive multifocal leukoencephalopathy (PML) with Tecfidera (dimethyl fumarate).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Tecfidera (dimethyl fumarate)